Madison teen advocate for diabetes research dies - 2.4.10
- 13 year old Jesse Alswager died yesterday. Alswager worked tirelessly to find a cure. In 2004, he appeared with Governor Doyle advocating for stem cell research. Alswager also testified before congress, pushing for diabetes and stem cell research funding.
Study: Politics affects views on stem-cell research - 2.4.10
- A recent UW-Madison study found that Wisconsin voters’ level of political activism on the issue of stem-cell research is more likely to be correlated to political ideology and media exposure than religion.
Plastic Surgery with No Knives No Scars on "Extra" - 2.4.10
- Women who are looking to reduce the appearance of wrinkles but are afraid of the pain and recovery time associated with traditional facelift now have a new option - the Stem Cell Lift (TM).
Vatican newspaper calls new stem cell source 'future of medicine' - 2.4.10
- 'We are studying a particular type of stem cell, the amniotic stem cell, that represents a 'first' in the course of our existence'
Cryo-Save appoints CEO - 2.4.10
- Stem cell bank Cryo-Save Group has appointed Arnoud van Tulder as chief executive from 1 May.
Fate Therapeutics, MIT Scientist Get Stem Cell Patent - 2.4.10
- Rudolf Jaenisch, a Massachusetts Institute of Technology scientist, will be granted a U.S. patent for conceiving a way to turn cells from mammals’ bodies into stem cells, a discovery also claimed by two other scientists.
CORD:USE Cord Blood Bank Featured Internationally on CNN en Espanol - 2.4.10
- CORD:USE Cord Blood Bank and its program at South Miami Hospital are being featured on CNN en Espanol's show "Salud." This story on the importance of cord blood donation aired this week and can be seen Friday, February 5 at 9:30 a.m. EST and Sunday, February 7 at 9 a.m. EST and 3 p.m. EST on CNN en Espanol. Additionally, the story can be viewed at www.corduse.com by clicking on this press release on the front page.
- Bioheart, Inc., (BHRT) announced today that the company has commenced work on its REGEN trial, a Phase I Clinical Trial to test genetically modified MyoCell(R) in patients suffering from Congestive Heart Failure (CHF).
- International Stem Cell Corporation (ISCO) announced today that its new cell production facility has passed final building inspection, which will enable development and manufacturing of the company and its partners' clinical-grade stem cell products.
Regenocyte Successfully Treats Cardiomyopathy Patient Using His Own Adult Stem Cells - 2.4.10
- Six months following the procedure, his Ejection Fraction – the rate at which the heart is able to expel blood - has improved a remarkable 18 percentage points.
South Dakota Senate Rejects Effort to Undermine Embryonic Stem Cell Ban - 2.4.10
- The South Dakota Senate voted down a bill Tuesday that would have sabotaged the state’s ban on embryonic stem-cell research. The Senate rejected S.B. 74 by a 21 - 12 margin, after the bill was substantially revised to permit South Dakotans to access embryonic stem cell treatments approved by the U.S. Food and Drug Administration.
Seeking hope for child's eyes, parents turn to China - 2.4.10
- If they can raise $35,000, they will take their daughter to China later this year so she can get at least six infusions of umbilical cord stem cells.
ThermoGenesis Signs Distribution Agreement With GE Healthcare - 2.4.10
- ThermoGenesis Corp. (KOOL) signed a new enhanced distribution agreement with GE Healthcare, a unit of General Electric Co. (GE), for its AXP AutoXpress System used in the processing of cord blood.
- ImmunoCellular Therapeutics (OTCBB: IMUC) announced today that Manish Singh, Ph.D., President and CEO will be presenting at the 2010 BIO CEO & Investor Conference on Tuesday, February 9 th at 10 a.m. eastern time. Hosted by the Biotechnology Industry Organization (BIO), the 12th Annual CEO & Investor Conference will take place at the Waldorf Astoria in New York.
BioShock 2: Secret Messages, Packages and Telegrams - 2.4.10
- The game, to be released February 9, is set in Rapture, a fictional underwater city that was designed in 1946 as a utopia for the intellectual elite. The city breaks down after scientists discover they can genetically re-engineer themselves through stem cells harvested from a sea slug that are mass-produced in the stomachs of young girls. The first BioShock game was set after that breakdown in 1960.
Gene doping risky for athletes - 2.4.10
- The Science article points to an Associated Press report that described an incident prior to the 2008 Olympic Games in Beijing in which a Chinese doctor offered to sell stem-cell therapy to a German reporter posing as a swimming coach.
Majority of Parkinson’s Patients Improved After German Stem Cell Treatment - 2.4.10
- The XCell-Center, Europe’s leading stem cell therapy provider has released results from a follow-up study of 50 Parkinson’s disease patients treated with autologous bone marrow stem cells. Overall, almost 60% improved following treatment.
Medical Council issues new rules on stem-cell research - 2.4.10
- A law professor Thursday slammed the Medical Council for issuing a new regulation requiring stem-cell researchers to seek additional approval from a newly set up national regulatory body, saying that the new rule would benefit private hospitals rather than foster research.
New State-Of-The-Art Technology To Accelerate Stem Cell Research At UC Riverside - 2.4.10
- Stem cell research at the University of California, Riverside is about to gather speed thanks to the establishment of a new Stem Cell Core Facility (SCCF) - a shared facility providing infrastructure, equipment, and trained personnel for doing stem cell research that ordinarily would not be available in most laboratories.
Scientists Map Epigenome of Human Stem Cells During Development - 2.4.10
- Scientists at The Genome Institute of Singapore (GIS) and The Scripps Research Institute (TSRI) led an international effort to build a map that shows in detail how the human genome is modified during embryonic development.
New Scaffold for Stem-Cell Growth Developed - 2.3.10
- A science group at the University of Washington has recently developed a new system of growing stem cells in the laboratory, without the risk of contamination. Their scaffold eliminates the possibility of these cells being invaded by animal byproducts, as was often the case in various studies. In fact, it was recently discovered that all embryonic stem cells (ESC) that scientists used in 2005 were contaminated, from the medium that was used in Petri dishes to grow them. Animal-based “feeder layers” are still widely used, and the new scaffold is designed specifically to eliminate them, ScienceDaily reports.
- StemCells, Inc. (Nasdaq:STEM) announced today that LifeTech Capital has initiated independent research coverage on the Company with a "Strong Speculative Buy" recommendation and a 12-18 month price target of $2.20 per share.
Stem cells: Science, economy edge religion at the polls - 2.3.10
- When it comes to stem cell research as a political issue, Wisconsin voters are more likely to be motivated by ideas of economic benefit and scientific progress than by religious objections, according to a new report.
Research and Markets: Investing in Stem Cell Companies in 2010 and Beyond - 2.3.10
- The first approval of stem cell-based therapeutic product will push the whole market forward not only financially but also acceptance of stem cells as the mode of therapy and eventually prevention of a variety of diseases by general public will increase.
'Clique' of scientists skewing stem cell research by influencing high-profile journals - 2.3.10
- A small clique of scientists are skewing stem cell research by unduly influencing which breakthroughs get published in high-profile journals, experts have warned.

